|
|
|
|
Editorial: the Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis
|
|
|
|
|
|
|
|
نویسنده
|
Naderi Nima
|
|
منبع
|
iranian journal of pharmaceutical research - 2015 - دوره : 14 - - کد همایش: - صفحه:1 -2
|
|
چکیده
|
Currently approved therapies for multiple sclerosis (ms) mostly directed towards palliating inflammation, in particular in those patients with the relapsing–remitting form of ms. however, in a significant number of patients, the disease might be worsen during time.
|
|
|
|
|
آدرس
|
shahid beheshti university of medical sciences, School of Pharmacy, Department of Pharmacology and Toxicology, ایران
|
|
پست الکترونیکی
|
naderi@sbmu.ac.ir
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|